N-METHYL-3-NITROPYRIDINE-2-CARBOXAMIDE
![]() |
- $439 - $1951.29
- Product name: N-METHYL-3-NITROPYRIDINE-2-CARBOXAMIDE
- CAS: 1061358-01-7
- MF: C7H7N3O3
- MW: 181.15
- EINECS:
- MDL Number:MFCD09909456
- Synonyms:2-Pyridinecarboxamide, N-methyl-3-nitro-;N-METHYL-3-NITROPICOLINAMIDE;N-METHYL-3-NITROPYRIDINE-2-CARBOXAMIDE
5 prices
Selected condition:
Brand
- Alichem
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 1g
- 5g
- ManufacturerAlichem
- Product number1061358017
- Product descriptionN-methyl-3-nitropyridine-2-carboxamide
- Packaging1g
- Price$663.57
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1061358017
- Product descriptionN-methyl-3-nitropyridine-2-carboxamide
- Packaging5g
- Price$1951.29
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0385201
- Product descriptionN-METHYL-3-NITROPYRIDINE-2-CARBOXAMIDE 95.00%
- Packaging5MG
- Price$504.3
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM316099
- Product descriptionN-Methyl-3-nitropicolinamide 95%
- Packaging1g
- Price$439
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11357863
- Product descriptionN-Methyl-3-nitropicolinamide 95+%
- Packaging1g
- Price$465
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1061358017 | N-methyl-3-nitropyridine-2-carboxamide | 1g | $663.57 | 2021-12-16 | Buy |
Alichem | 1061358017 | N-methyl-3-nitropyridine-2-carboxamide | 5g | $1951.29 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0385201 | N-METHYL-3-NITROPYRIDINE-2-CARBOXAMIDE 95.00% | 5MG | $504.3 | 2021-12-16 | Buy |
Chemenu | CM316099 | N-Methyl-3-nitropicolinamide 95% | 1g | $439 | 2021-12-16 | Buy |
Crysdot | CD11357863 | N-Methyl-3-nitropicolinamide 95+% | 1g | $465 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|